All News #Library
Biotech
Strand Therapeutics Presents at 44th JPM Healthcare Conference
15 Dec 2025 //
BUSINESSWIRE
Strand Therapeutics Elevates Prashant Nambiar To CSO
05 Nov 2025 //
BUSINESSWIRE
Dr. Jason J. Named Chief Medical Officer at Strand Therapeutics
21 Aug 2025 //
BUSINESSWIRE
MRNA Startup secures $153M Series B despite Policy Headwinds
07 Aug 2025 //
BIOSPACE
Strand Therapeutics Reveals Phase 1 Data for STX-001 at 2025 ASCO
28 May 2025 //
BUSINESSWIRE
STX-003 preclinical data for mRNA therapy in solid tumors
28 Apr 2025 //
BUSINESSWIRE
Strand Doses First Patient With STX-001 mRNA Therapy In Phase 1
30 May 2024 //
BUSINESSWIRE
Exclusive: Strand lays off 18% of staff
26 Jan 2024 //
ENDPTS
Strand Receives IND Clearance for Programmable mRNA Therapy STX-001
22 Jan 2024 //
BUSINESSWIRE
Strand Presents Preclinical Data Programmable mRNA Therapy STX-001 at AACR 2023
17 Apr 2023 //
BUSINESSWIRE

Market Place
Sourcing Support